Clinical Trial Update: PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial update of PEDS-C evaluating pegylated interferon with or without ribavirin in children with chronic hepatitis C; study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2013-07-01